Skip to main content


Log in

Long-term visual outcomes in intraocular retinoblastoma with eye preservation

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript



Inconsistent data exist on long-term visual outcomes in survivors of retinoblastoma. No studies have been reported on role of ocular coherence tomography (OCT) in predicting visual acuity. We assessed visual acuity in patients with retinoblastoma treated at our center in whom affected eyes were preserved.


Patients who had completed a 2-year follow-up and were more than 5 years of age at assessment were included. Clinical data were obtained from database and factors predicting visual acuity were analyzed. OCT was performed in these patients to assess central macular thickness (CMT).


Visual outcomes were assessed in 45 eyes of 43 patients, of which 38 (88 %) had bilateral retinoblastoma. The median age at diagnosis was 12 months. Sixty percent (27/45) had International classification of retinoblastoma group C or D disease with 40 % eyes showing macular lesions. The far visual acuity was better than 6/12 in 53 % (24/45), 6/12 to 6/60 in 40 % (18/45) and 6/60 in 7 % (6/60). Macular location and International classification of retinoblastoma predicted poor vision (p = 0.06 and 0.07, respectively). CMT was less than 200 μm in 3 of 36 eyes (8 %) and 1 eye showed epiretinal membrane. Radiotherapy was associated with foveal thinning (p = 0.003). Two of 3 eyes with foveal thinning had a vision of 6/60.


Good visual outcomes were observed in half of retinoblastoma patients treated with eye preservation. Macular location and International classification of retinoblastoma group C and D predicted poor visual acuity, while previous radiotherapy predicted foveal thinning, which was associated with poor visual acuity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others


  1. Houston SK, Murray TG, Wolfe SQ, Fernandes CE. Current update on retinoblastoma. Int Ophthalmol Clin. 2011;51:77–91.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276–80.

    Article  PubMed  Google Scholar 

  3. Shields CL, Shields JA. Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol. 2006;17:228–34.

    Article  PubMed  Google Scholar 

  4. Schefler AC, Abramson DH. Retinoblastoma: what is new in 2007–2008. Curr Opin Ophthalmol. 2008;19:526–34.

    Article  PubMed  Google Scholar 

  5. Berry JL, Jubran R, Wong K, Lee TC, Murphree AL, Kim JW. Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: the Children’s Hospital Los Angeles experience. Br J Ophthalmol. 2014;98:1061–5.

    Article  PubMed  Google Scholar 

  6. Migdal C. Bilateral retinoblastoma: the prognosis for vision. Br J Ophthalmol. 1983;67:592–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Desjardins L, Chefchaouni MC, Lumbroso L, Levy C, Asselain B, Bours D, et al. Functional results after treatment of retinoblastoma. J Publ Am Assoc Pediatr Ophthalmol Strabismus. 2002;6:108–11.

    Article  Google Scholar 

  8. Demirci H, Shields CL, Meadows AT, Shields JA. Long-term visual outcome following chemoreduction for retinoblastoma. Arch Ophthalmol Chic Ill. 1960;2005(123):1525–30.

    Google Scholar 

  9. Schefler AC, Cicciarelli N, Feuer W, Toledano S, Murray TG. Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology. 2007;114:162–9.

    Article  PubMed  Google Scholar 

  10. Narang S, Mashayekhi A, Rudich D, Shields CL. Predictors of long-term visual outcome after chemoreduction for management of intraocular retinoblastoma. Clin Exp Ophthalmol. 2012;40:736–42.

    Article  PubMed  Google Scholar 

  11. Hall LS, Ceisler E, Abramson DH. Visual outcomes in children with bilateral retinoblastoma. J Publ Am Assoc Pediatr Ophthalmol Strabismus. 1999;3:138–42.

    Article  CAS  Google Scholar 

  12. Weiss AH, Karr DJ, Kalina RE, Lindsley KL, Pendergrass TW. Visual outcomes of macular retinoblastoma after external beam radiation therapy. Ophthalmology. 1994;101:1244–9.

    Article  CAS  PubMed  Google Scholar 

  13. Lam BL, Judisch GF, Sobol WM, Blodi CF. Visual prognosis in macular retinoblastomas. Am J Ophthalmol. 1990;110:229–32.

    Article  CAS  PubMed  Google Scholar 

  14. Shields CL, Mashayekhi A, Luo CK, Materin MA, Shields JA. Optical coherence tomography in children: analysis of 44 eyes with intraocular tumors and simulating conditions. J Pediatr Ophthalmol Strabismus. 2004;41:338–44.

    PubMed  Google Scholar 

  15. Levin LA, Gragoudas ES, Lessell S. Endothelial cell loss in irradiated optic nerves. Ophthalmology. 2000;107:370–4.

    Article  CAS  PubMed  Google Scholar 

  16. Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15:95–100.

    Article  PubMed  Google Scholar 

  17. Shields CL, Manalac J, Das C, Saktanasate J, Shields JA. Review of spectral domain-enhanced depth imaging optical coherence tomography of tumors of the retina and retinal pigment epithelium in children and adults. Indian J Ophthalmol. 2015;63:128–32.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to S. Bakhshi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals: ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from parents of all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Batra, A., Pushker, N., Venkatesh, P. et al. Long-term visual outcomes in intraocular retinoblastoma with eye preservation. Clin Transl Oncol 18, 1034–1038 (2016).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: